a comparative , fixed-dose , parallel , randomized , blinded trial to define the efficacy and safety of a new once-a-day quinidine preparation , quiniday , at 1200 mg per day , was compared to quinidine sulfate ( as quinora , 300 mg four times daily , and quinidex extentabs , 600 mg twice daily ) and to quinidine gluconate ( as quinaglute dura-tabs , 648 mg twice daily ) .
C0072869
quinidine gluconate
C1097294
quinaglute